Does microbiota composition act as predictive signature for the evaluation of chemoimmunotherapy response efficacy?
- PMID: 38482237
- PMCID: PMC10932667
- DOI: 10.21037/jgo-23-888
Does microbiota composition act as predictive signature for the evaluation of chemoimmunotherapy response efficacy?
Keywords: Gut microbiota (GM); Streptococcus; immune response; intratumoral microbiota (ITM); neoadjuvant chemoimmunotherapy (NACI).
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-23-888/coif). The authors have no conflicts of interest to declare.
Comment on
-
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.Cancer Res. 2023 Sep 15;83(18):3131-3144. doi: 10.1158/0008-5472.CAN-22-2593. Cancer Res. 2023. PMID: 37433041
References
-
- Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. New York: Springer; 2017.